The rand was on track for its second day of gains on Tuesday as progress in finding a Covid-19 vaccine lifted risk sentiment.

US biotech firm Moderna said on Monday that an early trial of its coronavirus vaccine showed promising results as investors worry that prolonged lockdowns may sink the global economy deeper into recession...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.